bpc 157 for spine injury Orthopedic Use of BPC-157 Peptide Therapy for Pain Management
Description
It requires a prescription and as a controlled substance, supply is strictly monitored, and distribution is limited
It does not have the same level of clinical evidence as approved medications for inflammatory bowel disease, autoimmune disease, or other diagnosed inflammatory conditions
The peptide appears to shift macrophage polarization from pro-inflammatory M1 phenotypes toward anti-inflammatory M2 phenotypes, thereby facilitating tissue repair and regeneration
Scapular stabilization exercises improve upper back support for the cervical spine
Sermorelin acetate
